In addition to the RECORD study, a number of observational studies of the cardiovascular safety of rosiglitazone have been published.



Popular
type 2 diabetes type 1 diabetes Diabetes Complications diabetes research diabetes management managing diabetes JDRF diabetes support american diabetes association Diabetes Community women's health obesity type 2 diabetes risk children's health type 2 diabetes prevention kids with diabetes diabetes type 2 diabetes treatment insulin diabetes treatment obesity epidemic insulin resistance juvenile diabetes children with diabetes Tanya Zuckerbrot


